Treatment with MT inhibitor amiprophosmethyl (APM) reduced stromules, and co-treatment with AF and MT inhibitors decreased stromule frequency and length (Kwok and Hanson, 2003). The gene discussed is MCAT; the disease is atrial fibrillation.